TrivarX Limited (MDBIF)
OTCMKTS · Delayed Price · Currency is USD
0.0021
-0.0048 (-69.57%)
At close: Dec 19, 2024

TrivarX Statistics

Total Valuation

TrivarX has a market cap or net worth of 4.39 million. The enterprise value is 4.00 million.

Market Cap 4.39M
Enterprise Value 4.00M

Important Dates

The next estimated earnings date is Thursday, May 29, 2025.

Earnings Date May 29, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +61.38%
Shares Change (QoQ) +26.85%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 436.22M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.55
PB Ratio 0.62
P/TBV Ratio 2.51
P/FCF Ratio n/a
P/OCF Ratio 20.11
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -14.67
EV / Sales 3.12
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.02.

Current Ratio 1.11
Quick Ratio 1.05
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -26.42

Financial Efficiency

Return on equity (ROE) is -4.44% and return on invested capital (ROIC) is -2.61%.

Return on Equity (ROE) -4.44%
Return on Assets (ROA) -2.41%
Return on Invested Capital (ROIC) -2.61%
Return on Capital Employed (ROCE) -3.63%
Revenue Per Employee 205,885
Profits Per Employee -45,403
Employee Count 6
Asset Turnover 0.18
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -86.00% in the last 52 weeks. The beta is 0.88, so TrivarX's price volatility has been lower than the market average.

Beta (5Y) 0.88
52-Week Price Change -86.00%
50-Day Moving Average 0.03
200-Day Moving Average 0.11
Relative Strength Index (RSI) 40.37
Average Volume (20 Days) 9,048

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TrivarX had revenue of 1.24 million and -272,415 in losses. Loss per share was -0.00.

Revenue 1.24M
Gross Profit 1.23M
Operating Income -259,616
Pretax Income -272,415
Net Income -272,415
EBITDA -210,967
EBIT -259,616
Loss Per Share -0.00
Full Income Statement

Balance Sheet

The company has 500,364 in cash and 120,796 in debt, giving a net cash position of 379,567.

Cash & Cash Equivalents 500,364
Total Debt 120,796
Net Cash 379,567
Net Cash Per Share n/a
Equity (Book Value) 7.06M
Book Value Per Share 0.02
Working Capital 53,633
Full Balance Sheet

Cash Flow

Operating Cash Flow 218,298
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 99.26%, with operating and profit margins of -21.02% and -22.05%.

Gross Margin 99.26%
Operating Margin -21.02%
Pretax Margin -22.05%
Profit Margin -22.05%
EBITDA Margin -17.08%
EBIT Margin -21.02%
FCF Margin n/a

Dividends & Yields

TrivarX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -61.38%
Shareholder Yield -61.38%
Earnings Yield -6.21%
FCF Yield n/a

Stock Splits

The last stock split was on October 24, 2023. It was a reverse split with a ratio of 0.05.

Last Split Date Oct 24, 2023
Split Type Reverse
Split Ratio 0.05

Scores

TrivarX has an Altman Z-Score of -5.36. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.36
Piotroski F-Score n/a